FRACTURE RISK CALCULATOR - Key Persons
Job Titles:
- Professor
- Program Director - Cancer Ecosystems / Laboratory Head - Tumour Progression View Profile
Professor Alex Swarbrick leads a multidisciplinary cancer research laboratory focussed on identifying new biomarkers and therapeutic strategies in breast and prostate cancer and melanoma. He is an international leader in the application of single-cell and spatially-resolved 'omics' to cancer. He leads the international Breast Cancer Cellular Atlas Consortium and co-leads Garvan's Strategic Program in Cancer Ecosystems with Professor Paul Timpson.
Alex graduated with a BSc (Hons I) in Molecular and Cellular Biology from UNSW in 1995. After obtaining his PhD in 2003 he undertook postdoctoral training with Nobel laureate J. Michael Bishop at the University of California, San Francisco, supported by a CJ Martin Travelling Fellowship from the NHMRC.
In 2008 he established the Tumour Progression Laboratory at Garvan and in 2012 was appointed co-Head of the Breast Translational Oncology Program in the newly commissioned Kinghorn Cancer Centre. Alex is a Professor at UNSW and an NHMRC Senior Leadership Investigator.
Alex is the founding co-convenor of the the Australian Translational Breast and Prostate Cancer Symposium and is the immediate-past convenor of the Lorne Cancer Conference, Australia's pre-eminent multi-disciplinary cancer research conference. He chairs the Cancer Research Committee of the Cancer Council NSW and is deputy chair of UNSW's Cancer Theme.
Awards
2023 National Health and Medical Research Council Senior Leadership Investigator
2020 Petre Chair of Breast Cancer Research
2019 National Health and Medical Research Council Senior Research Fellowship
2013 National Health and Medical Research Council Career Development Fellowship II
2012 National Breast Cancer Foundation Fellowship
2011 NSW Premier's Award for Outstanding Research Fellow 2011
2009 CINSW Early Career Fellowship
2007 Sydney University Medal for Excellence in Medical Research
Education
1995 Bachelor of Science (Bachelor of Science (B.S)), Molecular Biology University of New South Wales, Australia
2003 Doctor of Philosophy (Doctor of Philosophy (Ph.D))University of New South Wales, Australia
Professor Alex Swarbrick leads a multidisciplinary cancer research laboratory focussed on identifying new biomarkers and therapeutic strategies in breast and prostate cancer and melanoma. He is an international leader in the application of single-cell and spatially-resolved 'omics' to cancer. He leads the international Breast Cancer Cellular Atlas Consortium and co-directs Garvan's Cancer Ecosystems Program with Professor Paul Timpson. Professor Swarbrick is an NHMRC Leadership Fellow and a Breast Cancer Research Foundation Investigator. He chairs the Cancer Research Committee of the Cancer Council NSW.
Ms McFadgen is the Chief Executive Officer, St Vincent's Health Network Sydney. She joined St Vincent's in 2018 and has held Executive roles in strategy, planning and business development across both St Vincent's Public Hospital in Melbourne and more recently at St Vincent's Health Network Sydney. Prior to joining St Vincent's, Ms McFadgen held senior clinical operational roles at Austin Health in Victoria. She has over 20 years' experience in the health sector in both strategy and clinical operations and is proud to lead the St Vincent's Health Network Sydney Team in providing the best patient outcomes and experiences for our community.
Job Titles:
- Professor
- Program Director - Translational Oncology / Laboratory Head - Oncology Translational Research View Profile
Professor Anthony Joshua BSc (Med) MBBS PhD FRACP, completed his medical oncology training at the Royal Prince Alfred hospital in Sydney, before moving to Toronto, Canada to complete a PhD at the University of Toronto. He then joined the Department of Medical Oncology at Princess Margaret Cancer Centre in Toronto as a staff oncologist, specialising in genito-urinary malignancy and melanoma with research interests in circulating tumour DNA, tumour heterogeneity, mechanisms of enzalutamide resistance and autophagy. He returned to Australia, joining The Kinghorn Cancer Centre and Garvan in 2015. He is also a Conjoint Professor at UNSW Sydney.
Ashleigh R Poh, Megan O'Brien, David Chisanga, Hong He, David Baloyan, Jasmin Traichel, Christine Dijkstra, Michaël Chopin, Stephen Nutt, Lachlan Whitehead, Louis Boon, Ashleigh Parkin, Clifford Lowell, Marina Pajic, Wei Shi, Mehrdad Nikfarjam, Matthias Ernst
Job Titles:
- Executive Director
- Professor
Professor Benjamin Kile is an internationally recognised medical researcher who has made significant contributions to the understanding of blood cells, cancer, and inflammatory disease. His work shed light on the mechanisms of programmed cell death, informing the development of the BH3 mimetics, a new class of cancer drugs approved by the FDA in 2016. Professor Kile has a distinguished research leadership background, having occupied senior roles at WEHI, Monash University, and the University of Adelaide. He made foundational contributions to the establishment of the National Drug Discovery Centre, the South Australian immunoGENomics Cancer Institute, and the Bragg Comprehensive Cancer Centre.
Role
Executive Director
Executive Director of the Garvan Institute of Medical Research, Professor Benjamin Kile is an internationally recognised medical researcher who has made contributions to the understanding of cancer, stem cells and inflammatory disease. His work has shed light on the mechanisms of programmed cell death, informing the development of the BH3 mimetics, a new class of cancer drugs approved by the FDA in 2016. Professor Kile has a distinguished research leadership background, having occupied senior roles at the Walter and Eliza Hall Institute, Monash University, and the University of Adelaide. He made foundational contributions to the establishment of the National Drug Discovery Centre, the South Australian immunoGENomics Cancer Institute, and the Bragg Comprehensive Cancer Centre.
Awards
2016 Fellow - Australian Academy of Health and Medical Sciences
2015 Merck Millipore Research Medal - Australian Society for Biochemistry & Molecular Biology
2013 Committee for Melbourne Future Focus Group Jack Smorgon Alumni Award
2013 Gottschalk Medal of the Australian Academy of Science
2011 National Health and Medical Research Council 10 of the Best Research Projects 2011
2010 Australian Federal Government Science Minister's Prize for Life Scientist of the Year
2008 Burnet Prize of the Walter and Eliza Hall Institute
2007 Australian Institute of Policy and Science Young Tall Poppy Award
2006 Charles Perkins Centre Award for Outstanding Contributions to Cardiovascular Research
2005 International Society on Thrombosis and Haemostasis Young Investigator Award
2005 International Society on Thrombosis and Haemostasis Young Investigator Award
1997 Dean's Honour List - Faculty of Science - University of Melbourne
Job Titles:
- Garvan Institute of Medical Research in 2015 As Deputy Director
- Professor
Professor Chris Goodnow holds The Bill and Patricia Ritchie Foundation Chair as Head of the Immunogenomics Laboratory, a NHMRC Senior Principal Research Fellow, and is Professor and Director of the Cellular Genomics Futures Institute at UNSW Sydney.
With an American father and Australian mother, Chris grew up in Washington DC before moving to Sydney as a teenager. He trained in veterinary medicine and surgery, immunochemistry and immunology at the University of Sydney and in DNA technology at Stanford University. After doctoral studies begun at the Walter and Eliza Hall Institute in Melbourne and performed at Sydney University, he joined the faculty of Stanford University Medical School and the Howard Hughes Medical Institute in 1990. There he established the concept of multiple immune tolerance checkpoints, a framework now widely used in cancer treatment with "checkpoint inhibitors", and revealed the function of key genes in these checkpoints including FAS, CD86, PTPN6/SHP1, and later AIRE.
To pioneer genome-wide analysis of the DNA sequences controlling the immune system, he joined the faculty at the Australian National University in 1997 as Professor and founding Director of the Medical Genome Centre, leading its development into a major national research facility, the Australian Phenomics Facility. That effort revealed critical, entirely unknown functions of fourteen essential genes controlling the immune system, including CARD11, ROQUIN1, HNRNPLL, THEMIS, DOCK8, ATP11C, SPPL2A, ZFP318, GSDMD and ETAA1, as well as four previously obscure genes in neurodegeneration and infertility.
Chris joined the Garvan Institute of Medical Research in 2015 as Deputy Director and to translate genomic DNA sequence analysis of the human immune system into understanding the cause of immune disorders and developing more effective, personalised treatments. In his time at Garvan, he has forged a close partnership between Garvan and Israel's Weizmann Institute of Science, and has overseen the development of the multi-million dollar Garvan-Weizmann Centre for Cellular Genomics, the only multidisciplinary centre of its kind in the southern hemisphere. He was key to the development of CIRCA (Clinical Immunogenomics Research Consortium Australia), a Garvan-led national initiative that seeks to diagnose, understand and treat individuals with rare immune disorders through a combination of genomic DNA sequencing, clinical expertise and biomedical research.
Chris is now leading Hope Research - a transformative research program that is an initiative of the Garvan-Weizmann partnership and is supported by The Bill and Patricia Ritchie Foundation. Hope Research aims to uncover a common cause for all autoimmune disease, which include more than 100 different diseases that collectively affect one in eight people. Using single cell DNA sequencing, Chris and his team are tracking down and identifying the ‘rogue' immune cells in the blood of adults with 44 autoimmune diseases, which drive the immune system to attack parts of the body.
Chris' research contributions have been recognised by numerous awards, including the American Association of Immunologists (AAI) Pharmingen Investigator Award, AAI Distinguished Lecturer, Australasian Society for Immunology Burnet Orator, Gottschalk Medal, Health Minister's Prize, Centenary Medal, Ramaciotti Medal, GSK Award for Research Excellence, William E. Paul Award. He is a Fellow of the Australian Academy of Science, Fellow of the Royal Society (UK), and Member of the US National Academy of Sciences. He was President of the Australasian Society for Immunology in 2015-2016.
Beyond his research endeavours, Chris enjoys spending time with his family and surfing at Sydney's Manly Beach and on the NSW South Coast. Surfing has been a passion since his school days, and he is well known in surfing circles for leading a 1980 expedition discovering the now-famous breaks in Indonesia's remote Mentawai Islands.
Awards
2018 William E Paul Memorial Award - The Foundation for Primary Immune Diseases
2013 Member of the US National Academy of Science
2012 Glaxo-Smith-Kline Award for Research Excellence
2010 NHMRC Australia Fellow
2010 The Ramaciotti Medal
2009 Fellow of the Royal Society
2007 Ramaciotti Major Research Award
2006 ARC Federation Fellow
2006 Centenary Medal
2005 Health Minister's Prize for Excellence in Medical Research
2005 ISI Highly Cited Researcher
2002 Fellow of the Australian Academy of Science
2001 Gottschalk Medal - Australian Academy of Science
1998 American Association of Immunologists Pharmingen Investigator Award
1992 Searle Scholar
1990 Investigator of the Howard Hughes Medical Institute
1989 Medical Foundation Postdoctoral Fellowship
1986 NH & MRC Biomedical Research Scholarship
1984 Honours Class I with B.V.Sc. degree; Honours Class I and University Medal with B.Sc.(Vet) degree
1979 John Gurner and Frederick Ebsworth Prize for Biology - University of Sydney
Job Titles:
- Associate Professor
- Professor
Associate Professor Cindy Ma heads the Human Immune Disorders Lab at the Garvan Institute of Medical Research. She is a member of Garvan Faculty, holds a conjoint appointment with UNSW Sydney (School of Clinical Medicine) and an NHMRC Investigator grant Fellow (L1).
Job Titles:
- Breast Cancer Research Lab
Job Titles:
- Director - Centre for Targeted Therapy ( Laboratory Head ) View Profile
- Professor
Job Titles:
- Director Centre for Population Genomics View Profile
- Director of the Centre for Population Genomics
- Professor
Role
Director Centre for Population Genomics
Professor Daniel MacArthur is the Director of the Centre for Population Genomics, established to solve the critical scientific, regulatory, and technical problems currently limiting the development of genomic medicine in Australia, and execute large-scale projects that will establish Australia's leadership in this field.
Daniel previously served as Co-Director of the Medical and Population Genetics Program at the Broad Institute of MIT and Harvard, and headed up a team jointly based at the Broad Institute, Massachusetts General Hospital, and Harvard Medical School. He co-directed the Broad Institute's Centre for Mendelian Genomics, which has sequenced and analysed genomic data from over 10,000 individuals from rare disease families and contributed to the discovery of more than 100 new rare disease genes.
He also led the development of the Genome Aggregation Database (gnomAD), the largest and most widely-used data set of human exome and genome sequence data, which has collated data from over 140,000 sequenced individuals.
David V Conti, Burcu F Darst, Lilit C Moss, Edward J Saunders, Xin Sheng, Alisha Chou, Fredrick R Schumacher, Ali Amin Al Olama, Sara Benlloch, Tokhir Dadaev, Mark N Brook, Ali Sahimi, Thomas J Hoffmann, Atushi Takahashi, Koichi Matsuda, Yukihide Momozawa, Masashi Fujita, Kenneth Muir, Artitaya Lophatananon, Peggy Wan, Loic Le Marchand, Lynne R Wilkens, Victoria L Stevens, Susan M Gapstur, Brian D Carter, Johanna Schleutker, Teuvo L J Tammela, Csilla Sipeky, Anssi Auvinen, Graham G Giles, Melissa C Southey, Robert J MacInnis, Cezary Cybulski, Dominika Wokołorczyk, Jan Lubiński, David E Neal, Jenny L Donovan, Freddie C Hamdy, Richard M Martin, Børge G Nordestgaard, Sune F Nielsen, Maren Weischer, Stig E Bojesen, Martin Andreas Røder, Peter Iversen, Jyotsna Batra, Suzanne Chambers, Leire Moya, Lisa Horvath, Judith A Clements, Wayne Tilley, Gail P Risbridger, Henrik Gronberg, Markus Aly, Robert Szulkin, Martin Eklund, Tobias Nordström, Nora Pashayan, Alison M Dunning, Maya Ghoussaini, Ruth C Travis, Tim J Key, Elio Riboli, Jong Y Park, Thomas A Sellers, Hui-Yi Lin, Demetrius Albanes, Stephanie J Weinstein, Lorelei A Mucci, Edward Giovannucci, Sara Lindstrom, Peter Kraft, David J Hunter, Kathryn L Penney, Constance Turman, Catherine M Tangen, Phyllis J Goodman, Ian M Thompson, Robert J Hamilton, Neil E Fleshner, Antonio Finelli, Marie-Élise Parent, Janet L Stanford, Elaine A Ostrander, Milan S Geybels, Stella Koutros, Laura E Beane Freeman, Meir Stampfer, Alicja Wolk, Niclas Håkansson, Gerald L Andriole, Robert N Hoover, Mitchell J Machiela, Karina Dalsgaard Sørensen, Michael Borre, William J Blot, Wei Zheng, Edward D Yeboah, James E Mensah, Yong-Jie Lu, Hong-Wei Zhang, Ninghan Feng, Xueying Mao, Yudong Wu, Shan-Chao Zhao, Zan Sun, Stephen N Thibodeau, Shannon K McDonnell, Daniel J Schaid, Catharine M L West, Neil Burnet, Gill Barnett, Christiane Maier, Thomas Schnoeller, Manuel Luedeke, Adam S Kibel, Bettina F Drake, Olivier Cussenot, Géraldine Cancel-Tassin, Florence Menegaux, Thérèse Truong, Yves Akoli Koudou, Esther M John, Eli Marie Grindedal, Lovise Maehle, Kay-Tee Khaw, Sue A Ingles, Mariana C Stern, Ana Vega, Antonio Gómez-Caamaño, Laura Fachal, Barry S Rosenstein, Sarah L Kerns, Harry Ostrer, Manuel R Teixeira, Paula Paulo, Andreia Brandão, Stephen Watya, Alexander Lubwama, Jeannette T Bensen, Elizabeth T H Fontham, James Mohler, Jack A Taylor, Manolis Kogevinas, Javier Llorca, Gemma Castaño-Vinyals, Lisa Cannon-Albright, Craig C Teerlink, Chad D Huff, Sara S Strom, Luc Multigner, Pascal Blanchet, Laurent Brureau, Radka Kaneva, Chavdar Slavov, Vanio Mitev, Robin J Leach, Brandi Weaver, Hermann Brenner, Katarina Cuk, Bernd Holleczek, Kai-Uwe Saum, Eric A Klein, Ann W Hsing, Rick A Kittles, Adam B Murphy, Christopher J Logothetis, Jeri Kim, Susan L Neuhausen, Linda Steele, Yuan Chun Ding, William B Isaacs, Barbara Nemesure, Anselm J M Hennis, John Carpten, Hardev Pandha, Agnieszka Michael, Kim De Ruyck, Gert De Meerleer, Piet Ost, Jianfeng Xu, Azad Razack, Jasmine Lim, Soo-Hwang Teo, Lisa F Newcomb, Daniel W Lin, Jay H Fowke, Christine Neslund-Dudas, Benjamin A Rybicki, Marija Gamulin, Davor Lessel, Tomislav Kulis, Nawaid Usmani, Sandeep Singhal, Matthew Parliament, Frank Claessens, Steven Joniau, Thomas Van den Broeck, Manuela Gago-Dominguez, Jose Esteban Castelao, Maria Elena Martinez, Samantha Larkin, Paul A Townsend, Claire Aukim-Hastie, William S Bush, Melinda C Aldrich, Dana C Crawford, Shiv Srivastava, Jennifer C Cullen, Gyorgy Petrovics, Graham Casey, Monique J Roobol, Guido Jenster, Ron H N van Schaik, Jennifer J Hu, Maureen Sanderson, Rohit Varma, Roberta McKean-Cowdin, Mina Torres, Nicholas Mancuso, Sonja I Berndt, Stephen K Van Den Eeden, Douglas F Easton, Stephen J Chanock, Michael B Cook, Fredrik Wiklund, Hidewaki Nakagawa, John S Witte, Rosalind A Eeles, Zsofia Kote-Jarai, Christopher A Haiman
Job Titles:
- Researcher
- Laboratory Head View Profile
Dr Ira Deveson is a mid-career researcher with expertise in clinical genomics, biotechnology development & bioinformatics. He leads Garvan's Genomic Technologies research lab, with a current focus on applications of long-read sequencing in clinical genomics. His work spans from computational methods development and software/hardware engineering, to large-scale genomic analysis of diverse cohorts in health and disease.
Dr Ira Deveson graduated with a Bachelor of Philosophy from the Australian National University in 2012. He completed a PhD at the Garvan Institute of Medical Research from 2014-2017, supervised by Prof John Mattick and Dr Tim Mercer. Dr Deveson's PhD focused on genome/transcriptome research and bioinformatics, and earned him recognition with the JD Catcheside prize from the Genomics Society of Australasia.
Dr Deveson was awarded an Early Career Fellowship from the Cancer Institute NSW (2018) and a prestigious NHMRC Investigator Grant (2020). He was appointed as Head of Garvan's Genomic Technologies Lab in 2020 and has since been awarded multiple significant MRFF grants to support his work on long-read sequencing technology development. In addition to his research role, Dr Deveson leads the Long-read Sequencing Team within Garvan's Sequencing Platform.
Awards
2017 DG Catcheside Prize - Genetics Society of Australasia: most outstanding Australasian PhD graduate in the field of genetics
2012 University Medal for Biology - Australian National University: outstanding graduate from the biological sciences
Job Titles:
- Group Leader of the Gut Immunogenomics Group
- Laboratory Head View Profile
Dr Kylie James is Group Leader of the Gut Immunogenomics Group. She completed her PhD at University of Queensland working with Dr Ashraful Haque at QIMR Berghofer Medical Research Institute. In this role, she determined the response kinetics of T helper cells during blood-stage malaria. Kylie then continued to pursue her interest in the immune system as a postdoctoral researcher with Dr Sarah Teichmann at the Wellcome Sanger Institute and Junior Research Fellow at Christ's College, University of Cambridge, UK. Her work redefined our understanding of the balance of immune and microbial cells across the healthy human colon. In 2021, Kylie returned to Australia to start her own team as Spinak Fellow and supported by an NHMRC Investigator Grant.
Dr Welly Firmanto joins Garvan after 10 years at Macquarie University, where he held the dual role of Executive Director, Faculty of Medicine, Health and Human Sciences, and Chief Operating Officer of MQ Health. Originally trained as an engineer with a PhD in telecommunication systems engineering, Dr Firmanto's formal education also includes an MBA and two other master's degrees. This, combined with over two decades of work experience in the public and private sectors, enables Dr Firmanto to lead the provision of professional services emphasising values based leadership with a strong focus on stakeholder engagement. He works well as a connector, a translator, a pacifier, building cross-functional alliances and converging disparate functions into a common purpose.
Associate Professor Elissa Deenick undertook her PhD with Dr Phil Hodgkin at the Centenary Institute/University of Sydney. Following her PhD, she moved to Canada to take up a postdoctoral position in the lab of Dr Pam Ohashi at the University of Toronto looking at the signalling pathways controlling T cell activation and tolerance.
Associate Professor Elissa Deenick's early research career started with a postdoctoral position at the University of Toronto looking at the signalling pathways controlling T cell activation and tolerance. In 2007 she returned to Sydney to work at Garvan, where she is currently Head of the Lymphocyte Signalling and Activation Lab. Here she has continued her interests in lymphocyte activation and differentiation and how this is controlled to ensure protection against infection while avoiding harmful immune responses like allergy and autoimmunity. She does this by studying both patients with immune disease and mouse models of these conditions.
Dr Nugent is the Chairman of Ausgrid and The Order of Australia Association Foundation Limited; Senior Independent Director of TPG Telecom; and a Non-Executive Director of Insurance Australia Group, the Australia Olympic Foundation and NPGA Foundation. She was previously Chairman of the National Disability Insurance Agency, the National Portrait Gallery of Australia, Veda Group, Australian Rail Track Corporation, Funds SA, Swiss Re (Australia) and Sydney Airport and a Non-Executive Director of Macquarie Group, among others. She is a Companion of the Order of Australia, a recipient of the Australian Government Centenary Medal and was awarded the Order of Merit by the Australian Olympic Committee. She has also been awarded Honorary Doctorates by the University of Queensland and Bond University.
Job Titles:
- Chief People Officer
- Garvan 's Chief People Officer
Isabella Bailey is Garvan's Chief People Officer. She brings 10 years of experience in human resources across the technology, telecommunications and professional services industries. Prior to joining Garvan, she was the Head of People at Trayport Ltd in London, UK. Isabella focuses on enhancing the employee experience and fostering a culture of continuous learning and belonging. She is currently building on her Bachelor of Science and Bachelor of Commerce, with a Master of Commerce. As a licensed Mental Health First Aid Instructor, Isabella believes strongly in promoting wellbeing and inclusion in the workplace. Her passion lies in empowering individuals and teams to reach their full potential.
Job Titles:
- Head - Clinical Diabetes and Metabolism View Profile
- Professor
Professor Jerry Greenfield and Dr Snaith established the Garvan Institute's ‘Australian Type 1 Diabetes Mellitus Adjuncts Group' (AUS-TAG) in 2023. The AUS-TAG mission is to prolong the life of Australians living with type 1 diabetes by preventing cardiovascular disease through novel repurposing of cardioprotective medications. AUS-TAG specialises in conducting clinical trials in type 1 diabetes. These studies include detailed mechanistic studies examining the phenotype of metabolic health in type 1 diabetes, and the physiological impacts of adjunctive therapies on cardiometabolic health in type 1 diabetes.
Ms Segal is the chairman of AICC (NSW), General Sir John Monash Foundation and the Independent Parliamentary Expenses Authority (IPEA). She is President of the Executive Council of Australian Jewry (ECAJ), a director of the Grattan Institute and of Rabobank Australia Limited. She is a member of the International Board of the Weizmann Institute of Science. She has been a senior regulator, lawyer and a director of other listed and government organisations and was previously the Deputy Chancellor of UNSW Sydney.
Job Titles:
- Head of the Clinical Genomics Laboratory
- Laboratory Head View Profile / Associate Professor Jodie Ingles
- Professor
Associate Professor Jodie Ingles is Head of the Clinical Genomics Laboratory. She is a cardiac genetic counsellor with more than 20 years' experience working with families with inherited cardiovascular diseases and sudden cardiac death. A/Prof Ingles is a Heart Foundation Future Leader Fellow, receiving the Shirley E. Freeman award for innovation in 2022. In 2019 she was awarded an NHMRC Excellence Award. Her team is focused on finding ways to use cardiac genomics and genetic counselling to improve diagnosis, management and care for families with inherited cardiovascular diseases.
Job Titles:
- Head of the Computational Genomics Laboratory
- Professor
- Program Director - Translational Genomics / Director Garvan - Weizmann Centre for Cellular Genomics View Profile
Professor Joseph Powell is Head of the Computational Genomics Laboratory and Director of the UNSW Cellular Genomics Futures Institute. Professor Powell's research focuses on how the functional mechanisms of genetic variants contribute to disease susceptibility at a cellular level and ultimately influence outcomes. In 2015 he was awarded the prestigious Commonwealth Health Minister's Medal for Excellence in Medical Research in the same year and an NHMRC Research Excellence Award.
Job Titles:
- Associate Professor
- Cancer Institute NSW Fellow
Liz is a Cancer Institute NSW Fellow, and a recipient of the Mavis Robertson fellowship from the NBCF. She is an Associate Editor for the journals Oncogenesis and Endocrine Oncology.
Job Titles:
- Director of the Garvan Research Foundation
- Director, Garvan Research Foundation
Mara-Jean Tilley is the Director of the Garvan Research Foundation, Garvan's marketing and fundraising arm. Since her commencement at Garvan in 2011, her leadership has been instrumental in the sustained growth and increased impact of the Foundation. Prior to joining Garvan, Mara-Jean was the Foundation Executive at Sydney Theatre Company, where she held a variety of positions over more than eight years with the organisation. She is a member of the Perpetual Foundation and the Centenary Foundation Advisory Committee.
Professor Paul Timpson completed his PhD with Professor Margaret Frame at the Beatson Institute for Cancer Research, UK in 2002 where he assessed the interplay between Src family kinases and the actin cytoskeleton during cancer cell invasion, focusing on the role of Rho family GTPases. He then moved to the Garvan Institute of Medical Research in 2003 to work with Professor Roger Daly investigating the role of the actin-binding protein cortactin in growth factor receptor trafficking in breast cancer and head and neck cancers.
Paul was awarded an AstraZeneca Postdoctoral Research Fellowship allowing him to return to the Beatson Institute in 2007, to work with Professor Kurt Anderson in collaboration with AstraZeneca Advanced Technology Laboratories. This ongoing work has focused upon the development of novel multi-disciplinary live imaging techniques to investigate molecular dynamics of cancer cells in vivo.
Having returned to Australia to establish a research group in November 2012 within the Cancer Program, Paul aims to understand disease in the context of the surrounding environment using cutting edge in vitro and in vivo imaging technology. Pinpointing the molecular drivers of cancer progression and the environmental cues that cause resistance to current systemic therapy are the focus of his research.
Awards
2023 NHMRC Investigator Grant - Australia
2018 NHMRC Senior Research Fellowship - Australia
2013 CINSW Fellowship - NSW - Sydney - Australia
2012 Australian Research Council (ARC) Future Fellowship - Australia
2011 European Association for Cancer Research Award (EACR) Australia
2010 Actin Prize - Bristol - UK
2010 Cancer Research UK - CRUK posdoctoral Research Award - UK
2007 AstraZeneca Research Fellowship - UK
2004 AMGEN Postdoctoral Early Career Research prize - Australia
2001 Beatson Institute PhD Career Development award - Glasgow - UK
2001 Cancer Research Campaign - PhD Award - London - UK
1998 GlaxoWellcome - University (Hons) award - Pharmacology - UK
Associate Professor Marina Pajic completed her PhD in the laboratory of Professor Michelle Haber at the Children's Cancer Institute (CCI), University of New South Wales, where she investigated chemoresistance mechanisms in childhood cancers, supported by a University Postgraduate Award and a CCI Postgraduate Scholarship. In 2006, Marina moved to work with Professor Piet Borst at the Netherlands Cancer Institute where she developed physiologically-relevant mouse models to study chemotherapy resistance and discovered new mechanisms which guide survival of therapy-resistant cancer-initiating cells during a process termed "transient dormancy".
Associate Professor Owen Siggs is a mid-career clinician-scientist and Snow Fellow. He is a member of the Garvan Faculty and Centre for Population Genomics, head of the Genomic Medicine Lab, and co-Director of the Garvan Genomics and Inherited Disease Program.
Job Titles:
- Founding Partner of OneVentures
Dr Kelly is a Founding Partner of OneVentures and serves on the investment committee of OneVentures' three main Funds, chairing the Healthcare Fund III Investment Committee, and leads the healthcare and biotechnology practice across the firm. He is currently Chair on the boards of OneVentures investee companies Vaxxas and Hatchtech and is non-executive director of BiVACOR, Clinical Genomics and Prota Therapeutics. Dr Kelly is an Australian physician and serial biotechnology entrepreneur with over 30 years' experience in developing and commercialising biomedical innovations in the US, Europe, UK and Australia. While in the UK and US he led early-stage and mid-stage companies, public and private, with a record of achievement in transforming ideas, technologies and products into sustainable successful businesses and delivering strong returns for shareholders and investors as a founder and CEO.
Job Titles:
- Professor
- Program Director - Cancer Ecosystems / Laboratory Head - Invasion and Metastasis View Profile
Job Titles:
- Professor
- Program Director - Cancer Plasticity & Dormancy / Laboratory Head - Bone Biology View Profile
Job Titles:
- Chief Operating Officer at the St Vincent 's Centre for Applied Medical Research
Associate Professor Philip Cunningham OAM is the Chief Operating Officer at the St Vincent's Centre for Applied Medical Research and Chief Scientist at the NSW State Reference Laboratory for HIV at St Vincent's Hospital. He is Co-Chair of the National HIV Testing Policy Expert Reference Group, a visiting senior research fellow at the Kirby Institute, UNSW Sydney, and former Vice President of the Australasian Society of HIV Medicine (ASHM).
Job Titles:
- Professor
- Program Director - Immune Biotherapies / Laboratory Head - B Cell Biology View Profile
Job Titles:
- Chief Strategy Officer at St Vincent 's Health Australia
Dr Marshall is the Chief Strategy Officer at St Vincent's Health Australia, responsible for strategy development and delivery across its portfolio of private hospitals, aged care services, research partnerships, and virtual and at-home care. Dr Marshall interrupted his medical training with the Royal Australasian College of Physicians to pursue a Master in Public Administration (Health Policy) at Columbia University, supported by a Fulbright Scholarship. From there, he joined Boston Consulting Group where he led strategy and transformation efforts for governments, hospital providers, private health insurers and other large public and private organisations in Australia and the UK. He has also worked on cost-effectiveness analyses as a Consultant to the World Health Organization and on health system reform as a Policy Advisor to the Department of Prime Minister and Cabinet.
Nominated by the Federal Minister for Health Professor Reddel is a medical oncologist, molecular geneticist and an internationally renowned expert on cancer cell immortalisation. He is Executive Director of Children's Medical Research Institute (CMRI), Westmead, the Sir Lorimer Dods Professor of the University of Sydney, and a Fellow of the Australian Academy of Science, the Australian Academy of Health and Medical Sciences, the Royal Society of NSW, and the Royal Australasian College of Physicians.
Job Titles:
- Head of the Department of Medical Genomics at the Royal Prince Alfred Hospital
Nominated by the NSW Minister for Health Professor Trent is Head of the Department of Medical Genomics at the Royal Prince Alfred Hospital and Director for the Institute of Precision Medicine & Bioinformatics at the Sydney Local Health District. He is the President of the School Council for the Sydney Boys High School, and past Secretary of the Sydney Girls High School Foundation. He is a fellow of the Royal Australasian College of Physicians, the Royal College of Pathologists of Australasia, and of the Australian Academy of Technology and Engineering.
Nominated by the Federal Minister for Health
Dr Scrimshaw is the Garvan Research Foundation Board Chairman and a Non-Executive Director of the Garvan Institute of Medical Research. He is currently Executive Chairman of Peak Rare Earths Ltd, Deputy Chairman of Ignition Wealth P/L, Non-Executive Chairman of ARI P/L and Scrimshaw Nominees P/L and also of Australian Philanthropic Fund, the Scrimshaw Foundation. Previously, he has held senior executive positions at Fortescue Metals Group Ltd (FMG), Commonwealth Bank, Optus and IBM. He was also Non-Executive Chairman at Sirius Minerals plc, and Executive Director at FMG, and Non-Executive Director of Commonwealth Properties Ltd, EDS Australia, Mobilesoft, Telecom New Zealand Australia P/L, and Athletics Australia.
Job Titles:
- Chairman
- Public Company Director
Mr Perkins is an experienced public company director and has extensive Australian and international experience as a leading corporate advisor on strategy, mergers and acquisitions and capital markets matters. Mr Perkins is Chairman of Woolworths Group Limited and Origin Energy Limited and a non-executive Director of Brambles Limited. He is founding Chairman of Sweet Louise, a charity dedicated to supporting women with metastatic breast cancer. He held senior executive leadership positions at Deutsche Bank from 1999 to 2013, including Managing Director and Head of Corporate Finance for Australia and New Zealand, membership of the Asia Pacific Corporate and Investment Bank Management Committee and Chief Executive Officer of Deutsche Bank New Zealand.
Job Titles:
- Independent Chairman of the ASX
Mr Johns is the independent Chairman of the ASX listed Goodman Group and a director of the European Australia Business Council. He is a former chairman and non-executive director of three ASX listed entities - Brambles Limited, Leighton Holdings Limited and Spark Infrastructure Group - and a former Finance Director and, upon his retirement from executive duties, a non-executive director of the Westfield Group. He has a Bachelor of Economics degree from the University of Sydney and is a Fellow of the Institute of Chartered Accountants in Australia and the Australian Institute of Company Directors.
Job Titles:
- Professor
- Program Director - Precision Immunology / Laboratory Head - Intravital Microscopy View Profile
Job Titles:
- Communications Manager
- Media Enquiries